Abiopharma

🔍 Purdy Graham (Director)

Company: Turning Point Brands, Inc. (TPB)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 8,638 shares of Common Stock at $86.83 per share (Direct)
  Date: 2026-03-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 265,983.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Forward contract (Derivative)
  Date: 2026-03-24 | Code: H | shares_owned_after: 140,140.00 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: The reported transaction involved the reporting person's receipt of a grant of 8,638 restricted stock units under Turning Point Brands, Inc.'s 2021 Equity Incentive Plan. The total reported in Column 5 includes 27,094 restricted stock units and 238,889 shares of common stock.
• F2: On December 8, 2025, the reporting person entered into a financing transaction with an unaffiliated dealer to receive approximately $12.3 million secured by a pledge of up to 140,140 shares of the issuer's common stock (the "Pledged Shares"). Beginning on the maturity date of December 10, 2026, the reporting person is obligated to repay the lender in cash or at the reporting person's election to deliver up to 140,140 shares of the Issuer's common stock at a price per share ranging from $91.50 to $104.45 based on the then prevailing market price. The reporting person retains beneficial ownership of the Pledged Shares, including dividend and voting rights.